Results 131 to 140 of about 5,327 (168)
Some of the next articles are maybe not open access.
Human Placental Transfer of an Antifibrinolytic Agent (AMCA)
Acta Obstetricia et Gynecologica Scandinavica, 1970Abstract. A fibrinolytic inhibitor AMCA (trans pâaminomethyl cyclohexane carboxylic acid) was given i.v. in a dose of 0.01 g/kg bodyweight to 12 mothers about to be delivered by Caesarean section. Immediately after delivery the concentration of AMCA was determined in the maternal blood and in cord blood.
S, Kullander, I M, Nilsson
openaire +2 more sources
Fibrinolysis, Antifibrinolytic Agents, and Perioperative Considerations
2021Fibrinolysis is an integral component of hemostasis that acts to regulate fibrin formation. Its actions are counterbalanced by the coagulation process, maintaining against excess clot formation or hemorrhage. Excessive release of plasmin through surgery or other means can result in a pathophysiological state characterized by bleeding, inflammation, and
openaire +1 more source
A Direct Antifibrinolytic Agent in Major Orthopedic Surgery
Orthopedics, 2004abstract Aprotinin is a potent pharmacological agent that reduces bleeding. In current surgical practices, the rate of blood transfusions has decreased with the use of aprotinin. Recently, studies using aprotinin have been conducted in orthopedic surgery.
openaire +2 more sources
Studies on an antifibrinolytic agent trans-AMCHA
Acta Medicinae Okayama, 1968Lysis of fibrin was first recognized by MORGAGNI in 1769, observing a liquid blood in a patient of acute death, and the phenomenon was named as fibrinolysis by DASTRE in 1893. In 1937, MACFARLANE recognized in a patient after cholecystectomy that the blood clot was lysed completely in the following morning.
Sunada, Terutake +5 more
openaire +2 more sources
Antifibrinolytic Agents in Traumatic Hemorrhage
Annals of Epidemiology, 2006openaire +2 more sources
Antifibrinolytic Agents for Hemoptysis Management in Adults With Cystic Fibrosis
Chest, 2019Hanny Al-Samkari +2 more
exaly